Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.

Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ.

Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.

PMID:
18769331
[PubMed - indexed for MEDLINE]
2.

Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.

Ottesen GL.

APMIS Suppl. 2003;(108):1-67. Review.

PMID:
12874968
[PubMed - indexed for MEDLINE]
3.

Lobular neoplasia of the breast: an update.

Contreras A, Sattar H.

Arch Pathol Lab Med. 2009 Jul;133(7):1116-20. doi: 10.1043/1543-2165-133.7.1116. Review.

PMID:
19642738
[PubMed - indexed for MEDLINE]
4.

Challenges in the management of pleomorphic lobular carcinoma in situ of the breast.

Masannat YA, Bains SK, Pinder SE, Purushotham AD.

Breast. 2013 Apr;22(2):194-6. doi: 10.1016/j.breast.2013.01.003. Epub 2013 Jan 26. Review.

PMID:
23357705
[PubMed - indexed for MEDLINE]
5.

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.

Spyratos F, Ferrero-Poüs M, Trassard M, Hacène K, Phillips E, Tubiana-Hulin M, Le Doussal V.

Cancer. 2002 Apr 15;94(8):2151-9. Review.

PMID:
12001111
[PubMed - indexed for MEDLINE]
6.

Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology.

Lishman SC, Lakhani SR.

Histopathology. 1999 Sep;35(3):195-200. Review.

PMID:
10469210
[PubMed - indexed for MEDLINE]
7.

Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.

Jacobs M, Fan F, Tawfik O.

Ann Diagn Pathol. 2012 Jun;16(3):185-9. doi: 10.1016/j.anndiagpath.2011.10.001. Epub 2011 Dec 24. Review.

PMID:
22197540
[PubMed - indexed for MEDLINE]
8.

Small cell carcinoma of the breast.

Mirza IA, Shahab N.

Semin Oncol. 2007 Feb;34(1):64-6. Review.

PMID:
17270668
[PubMed - indexed for MEDLINE]
9.

Molecular evolutionary patterns in breast cancer.

Shackney SE, Silverman JF.

Adv Anat Pathol. 2003 Sep;10(5):278-90. Review.

PMID:
12973049
[PubMed - indexed for MEDLINE]
10.

Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.

Shimizu S, Kitamura H, Ito T, Nakamura T, Fujisawa J, Matsukawa H.

Pathol Int. 1998 Jul;48(7):549-56. Review.

PMID:
9701019
[PubMed - indexed for MEDLINE]
11.

Lobular neoplasia: morphology, biological potential and management in core biopsies.

O'Malley FP.

Mod Pathol. 2010 May;23 Suppl 2:S14-25. doi: 10.1038/modpathol.2010.35. Review.

PMID:
20436498
[PubMed - indexed for MEDLINE]
Free Article
12.

Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.

Skalova A, Ryska A, Kajo K, Di Palma S, Kinkor Z, Michal M.

Histopathology. 2005 Jan;46(1):43-9. Review.

PMID:
15656885
[PubMed - indexed for MEDLINE]
13.

Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.

Vargas AC, Lakhani SR, Simpson PT.

Future Oncol. 2009 Mar;5(2):233-43. doi: 10.2217/14796694.5.2.233. Review.

PMID:
19284381
[PubMed - indexed for MEDLINE]
14.

Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.

Butler D, Rosa M.

Arch Pathol Lab Med. 2013 Nov;137(11):1688-92. doi: 10.5858/arpa.2012-0603-RS. Review.

PMID:
24168512
[PubMed - indexed for MEDLINE]
15.

[Lobular neoplasia].

Sigal-Zafrani B, Vincent-Salomon A, Penault-Llorca F, Sastre-Garau X.

Ann Pathol. 2003 Dec;23(6):547-53. Review. French.

PMID:
15094592
[PubMed - indexed for MEDLINE]
16.

New trends of immunohistochemistry for making differential diagnosis of breast lesions.

Moriya T, Kasajima A, Ishida K, Kariya Y, Akahira J, Endoh M, Watanabe M, Sasano H.

Med Mol Morphol. 2006 Mar;39(1):8-13. Review.

PMID:
16575508
[PubMed - indexed for MEDLINE]
17.

The "Rosen Triad": tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions.

Brandt SM, Young GQ, Hoda SA.

Adv Anat Pathol. 2008 May;15(3):140-6. doi: 10.1097/PAP.0b013e31816ff313. Review.

PMID:
18434766
[PubMed - indexed for MEDLINE]
18.

[Recent data on lobular neoplasia of the breast: the pathologist's opinion].

Bibeau F, Borrelly C, Chateau MC, Saingra B, Lemanski C, Masson B, Rouanet P, Gutowski M.

Bull Cancer. 2005 May 1;92(5):453-8. Review. French.

PMID:
15932809
[PubMed - indexed for MEDLINE]
19.

Lobular in situ neoplasia and columnar cell lesions: diagnosis in breast core biopsies and implications for management.

Pinder SE, Provenzano E, Reis-Filho JS.

Pathology. 2007 Apr;39(2):208-16. Review.

PMID:
17454750
[PubMed - indexed for MEDLINE]
20.

Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?

Pieri A, Harvey J, Bundred N.

World J Clin Oncol. 2014 Aug 10;5(3):546-53. doi: 10.5306/wjco.v5.i3.546. Review.

PMID:
25114868
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk